Anti-cancer activities of 1,4-naphthoquinones: A QSAR study

Anti-Cancer Agents in Medicinal Chemistry

Volumn 6, Issue 5, 2006, Pages 489-499

  Verma, Rajeshwar P ^a  

^a POMONA COLLEGE   (United States)

Author keywords

1,4 naphthoquinones; Hydrophobicity; Molar refractivity; Quantitative structure activity relationships

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 2 (1 AZIDOALKYL) 5,8 DIMETHOXY 1,4 NAPHTHOQUINONE DERIVATIVE; 2 (1 HYDROXYIMINOALKYL) 5,8 DIMETHOXY 1,4 NAPHTHOQUINONE DERIVATIVE; 6 (1 ACYLOALKYL) 5,8 DIMETHOXY 1,4 NAPHTHOQUINONE DERIVATIVE; 6 (1 AZIDOALKYL) 5,8 DIMETHOXY 1,4 NAPHTHOQUINONE DERIVATIVE; 6 (1 HYDROXYIMINOALKYL) 5,8 DIMETHOXY 1,4 NAPHTHOQUINONE DERIVATIVE; 6 (1 PROPYLOXYIMINOALKYL) 5,8 DIMETHOXY 1,4 NAPHTHOQUINONE DERIVATIVE; 6 ACYL 5,8 DIMETHOXY 1,4 NAPHTHOQUINONE DERIVATIVE; ANION; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; DAUNORUBICIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; FLAVOPROTEIN; HYDROXYL RADICAL; LAWSONE; MENADIONE; MITOMYCIN; MITOXANTRONE; OXYGEN; PLUMBAGIN; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; SAINTOPIN; SEMIQUINONE; SUPEROXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; ARYLATION; CANCER CELL CULTURE; CHEMICAL INTERACTION; DNA STRAND BREAKAGE; DRUG CYTOTOXICITY; DRUG MECHANISM; ELECTRON TRANSPORT; ENZYME INHIBITION; HUMAN; HYDROPHOBICITY; NONHUMAN; OXIDATION REDUCTION REACTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SOLID TUMOR;

EID: 33748605052     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152006778226512     Document Type: Review

References (56)

1. Foye, M. O. In Cancer Chemotherapeutic Agents. American Chemical Society, Washigton, DC, 1995.
2. Leopold, W. R.; Shillis, J. L.; Mertus, A. E.; Nelson, J. M.; Roberts, B. J.; Jackson, R. C. Cancer Res. 1984, 44, 1928.
3. Silverman, R. B. In The Organic Chemistry of Drug Design and Drug Action. Academic Press, New York, 1992.
4. Tewey, K. M.; Chen, G. L.; Nelson, E. M.; Liu, L. F. J. Biol. Chem. 1984, 259, 9182.
5. Lown, J. W.; Sim, S. K.; Majumdar, K. C.; Chang, R. Y. Biochem. Biophys. Res. Commun. 1977, 76, 705.
6. Klotz, L.-O.; Patak, P.; Ale-Agha, N.; Buchczyk, D. P.; Abdelmohsen, K.; Gerber, P. A.: von Montfort. C.: Sies. H. Cancer Res. 2002, 62, 4922.
7. Babich, H.; Stern, A.; Monday, R. Toxicology Letters 1993, 69, 69.
8. Salmon-Chemin, L.; Buisine, E.; Yardley, V.; Kohler, S.; Debreu, M.-A.; Landry, V.; Sergheraert, C.; Croft, S. L.; Krauth-Siegel, R. L.; Davioud-Charvet, E. J. Med Chem. 2001, 44, 548.
9. Inbaraj, J. J.; Chignell, C. F. Chem. Res. Taxicol. 2004, 17, 55.
10. Huang, S.-T.; Kuo, H.-S.; Hsiao, C.-L.; Lin, Y.-L. Bioorg. Med. Chem. 2002, 10, 1947.
11. Tandon, V. K.; Chhor, R. B.; Singh, R. V.; Rai, S.; Yadav, D. B. Bioorg. Med. Chem. Lett. 2004, 14, 1079.
12. Sasaki, K.; Abe, H.; Yoshizaki, F. Biol. Pharm. Bull. 2002, 25, 669.
13. Lien, J.-C.; Huang, L.-J.; Teng, C.-M.; Wang, J.-P.; Kuo, S.-C. Chem. Pharm. Bull. 2002, 50, 672.
14. Huang, L.-J.; Chang, F.-C.; Lee, K.-H.; Wang, J.-P.; Teng, C.-M.; Koo, S.-C. Bioorg. Med. Chem. 1998, 6, 2261.
15. Lien, J.-C.; Huang, L.-J.; Wang, J.-P.; Teng, C.-M.; Lee, K.-H.; Kuo, S.-C. Chem. Pharm. Bull. 1996, 44, 1181
16. Len, J.-C.; Huang, L.-J.; Teng, C.-M.; Wang, J.-P.; Kuo, S.-C. Chem. Pharm. Bull. 2002, 50, 672.
17. Jin, Y.-R.; Ryu, C.-K.; Moon, C.-K.; Cho, M.-R.; Yon, Y.-P. Pharmacology 2004, 70, 195.
18. Yuk, D.-Y.; Ryu, C.-K.; Hong, J.-T.; Chung, K.-H.; Kang, W.-S.; Kim, Y.; Yoo, H.-S.; Lee, M.-K.; Lee, C.-K.; Yun, Y.-P. Biochem. Pharmacol. 2000, 60, 1001.
19. Zhang, Y.-H.; Chung, K.-H.; Ryu, C.-K.; Ko, M.-H.; Lee, M.-K.; Yon, Y.-P. Biol. Pharm. Bull. 2001, 24, 618.
20. Tandon, V. K.; Singh, R. V.; Rai, S.; Chhor, R. B.; Khan, Z. K. Bollettino Chimico Farmaceutico 2002, 141, 304.
21. Ilina, T. V.; Semenova, E. A.; Pronyaeva, T. R.; Pokrovskii, A. G.; Nechepurenko, I. V.; Shults, E. E.; Andreeva, O. I.; Kochetkov, S. N.; Tolstikov, G. A. Doklady Biochem. Biophys. 2002, 382, 56.
22. da Silva, A. J. M.; Buarque, C. D.; Brito, F. V.; Aurelian, L.; Macedo, L. F.; Malkas, L. H.; Hickey, R. J.; Lopes, D. V. S.; Noel, F.; Murakami, Y. L. B.; Silva, N. M. V.; Melo, P. A.; Caruso, R. R. B.; Castro, N. G.; Costa, P. R. R. Bioorg. Med. Chem. 2002, 10, 2731.
23. Ravelo, A. G.; Estevez-Braun, A.; Chavez-Orellana, H.; Perez-Sacau, E.; Mesa-Siverio, D. Curr. Topics Med. Chem. 2004, 4, 241.
24. Ting, C.-Y.; Hsu, C.-T.; Hsu, H.-T.; So, J.-S.; Chen, T.-Y.; Tam, W.-Y.; Koo, Y.-H.; Whang-Peng, J.; Liu, L. F.; Hwang, J. Biochem. Pharmacol. 2003, 66, 1981.
25. Ishiguro, K.; Oku, H. Foods & Food Ingredients Journal of Japan 2004. 209. 13.
26. Kim, H. J.; Kang, S. K.; Mun, J. Y.; Chun, Y. J.; Choi, K. H.; Kim, M. Y. FEBS Lett. 2003, 555, 217.
27. Kim, H. J.; Mun, J. Y.; Chun, Y. J.; Choi, K. H.; Ham, S. W.; Kim, M. Y. Arch. Pharmacal Res. 2003, 26, 405.
28. Gao, D.; Hiromura, M.; Yasui, H.; Sakurai, H. Biol. Pharm. Bull. 2002, 25, 827.
29. Richwien, A.; Wurm, G. Pharmazie 2004, 59, 163.
30. Wurm, G.; Schwandt, S. Pharmazie 2003, 58, 531.
31. Song, G.-Y.; Kim, Y.; You, Y.-J.; Cho, H.; Kim, S.-H.; Sok, D.-E.; Ahn, B.-Z. Arch. Pharm. Pharm. Med. Chem. 2000, 333, 87.
32. Chae, G.-H.; Song, G.-Y.; Kim, Y.; Cho, H.; Sok, D.-E.; Ahn, B.-Z. Arch. Pharm. Res. 1999, 22, 507.
33. Song, G.-Y.; Kim, Y.; Zheng, X.-G.; You, Y.-J.; Cho, H.; Chung, J.-H.; Sok, D.-E.; Ahn, B.-Z. Eur. J. Med. Chem. 2000, 35, 291.
34. Song, G.-Y.; Zheng, X.-G.; Kim, Y.; You, Y.-J.; Sok, D.-E.; Ahn, B.-Z. Bioorg. Med. Chem. Lett. 1999, 9, 2407.
35. Kim, Y.; You, Y.-J.; Ahn, B.-Z. Arch. Pharm. Pharm. Med. Chem. 2001, 334, 318.
36. Kumagai, Y.; Tsurutani, Y.; Shinyashiki, M.; Homma-Takeda, S.; Nakai, Y.; Yoshikawa, T.; Shimojo, N. Environ. Toxicol. Pharmacol. 1997, 3, 245.
37. Rahimipour, S.; Weiner, L.; Shrestha-Dawadi, P. B.; Bittner, S.; Koch, Y.; Fridkin, M. Letters in Peptide Sci. 1998, 5, 421.
38. Rahimipour, S.; Weiner, L.; Fridkin, M.; Shrestha-Dawadi, P. B.; Bittner, S. Letters in Peptide Sci. 1996, 3, 263.
39. O'Brien, P. Chem. Biol. Interact. 1991, 80, 1.
40. Verma, R. P.; Hansch, C. Bioorg. Med. Chem. 2004, 12, 5997.
41. Hansch, C.; Maloney, P. P.; Fujita, T.; Muir, R. M. Nature 1962, 194, 178.
42. Hansch, C.; Leo, A. In Exploring QSAR: Fundamentals and Applications in Chemistry and Biology; American Chemical Society; Washington, D.C. 1995.
43. Selassie, C. D.; Garg, R.; Kapur, S.; Kurup, A.; Verma, R. P.; Mekapati, S. B.; Hansch, C. Chem. Rev. 2002, 102, 2585.
44. Hansch, C.; Leo, A.; Mekapati, S. B.; Kurup, A. Bioorg. Med. Chem. 2004, 12, 3391.
45. Selassie, C. D.; Mekapati, S. B.; Verma, R. P. Curr. Topics Med. Chem. 2002, 2, 1357.
46. C-QSAR Program, BioByte Corp., 201W. 4th st., Suit 204, Claremont, CA 91711, USA. www.biobyte.com
47. Verloop, A. In The Sterimol Approach to Drug Design; Marcel Dekker: New York, 1987.
48. Hansch, C.; Steinmetz, W. E.; Leo, A. J.; Mekapati, S. B.; Kurup, A.; Hoekman, D. J. Chem. Inf. Comput. Sci. 2003, 43, 120.
49. Hansch, C.; Kurup, A. J. Chem. Inf. Comput. Sci. 2003, 43, 1647.
50. Verma, R. P.; Kurup, A.; Hansch, C. Bioorg. Med. Chem. 2005, 13, 237.
51. Verma, R. P.; Hansch, C. Bioorg. Med. Chem. 2005, 13, 2355.
52. Cramer, R. D., III; Bunce, J. D.; Patterson, D. E.; Frank, I. E, Quant. Struct.-Act. Relat. 1988, 7, 18.
53. Kyong-Up, B.; Yong, S. G.; Yong, K.; Dai-Eun, S.; Ahn, B.-Z. Arch. Pharm. Pharm. Med. Chem. 1997, 330, 377.
54. Chung, Y.; Shin, Y.-K.; Zhan, C.-G.; Lee, S.; Cho, H. Arch. Pharm. Res. 2004, 27, 893.
55. Huang, H.-S.; Chin, H.-F.; Yeh, P.-F.; Yuan, C.-L. Helvetica Chimica Acta 2004, 87, 999.
56. Perry, P. L; Gowan, S. M.; Reszka, A. P.; Polucci, P.; Jenkins, T. C.; Kelland, L. R.; Neidle, S. J. Med. Chem. 1998, 41, 3253.